Indian Biopharmaceuticals Market

 


The objective of this report is to evaluate the current state of the Indian biopharmaceuticals market, and forecast future revenues, revenue growth rate, and product pricing. The report also identifies the key challenges facing the industry and strategies to success in the light of such a competitive environment. Key issues and trends are highlighted and discussed relative to the future of the market. Market drivers as well as market restraints are evaluated and their impact on the revenue forecast discussed in detail. In addition to this, the study also provides a detailed product and competitive analysis.

Regular Price: USD 2,450

Special Price USD 1,715

30% OFF

* Required Fields

Regular Price: USD 2,450

Special Price USD 1,715

PAY BY INVOICE

Be the first to review this product

Table of Contents

Indian Biopharmaceuticals Market, Executive SummaryMarket OverviewIntroduction to the Biopharmaceuticals MarketObjectives and PurposeReport Scope and SegmentationReport StructureResearch FindingsMarket Opportunities and ForecastsMarket Measurement AnalysisStrategic ConclusionsIndian Biopharmaceuticals Market, The Indian Biopharmaceuticals Market (1999-2004)Market Overview and DefinitionsMarket Overview and DefinitionsMarket Engineering Measurement AnalysisMarket Engineering Measurement AnalysisChallenges Facing the Biopharmaceuticals MarketMarket DriversMarket RestraintsRevenue Forecasts (1999–2004)Demand AnalysisMarket PenetrationMergers and Acquisitions/Strategic AlliancesRegulatory EnvironmentRegulatory EnvironmentGuidelines for Generating Pre-clinical and Clinical Data for rDNA-Based VaccinesClinical TrialsFinancing PatternsConvertiblesRevenue-Based TransactionsPrivate Investment in Public Enterprises (PIPEs)Strategic Analysis and Forecast of the Indian Recombinant Vaccines MarketOverviewRevenue Forecasts (1999–2004)Pricing TrendsCompetitive StructureMarket Share AnalysisProduct AnalysisTechnology TrendsNew EntrantsStrategic Analysis and Forecasts of the Indian Recombinant Insulin MarketOverviewRevenue Forecasts (1999–2004)End-User PerspectivesPricing TrendsCompetitive StructureMarket Share AnalysisProduct AnalysisNew EntrantsStrategic Analysis and Forecast of the Indian Recombinant Erythropoietin MarketOverviewRevenue Forecasts (1999–2004)End-User PerspectivesPricing TrendsCompetitive StructureMarket Share AnalysisProduct AnalysisNew EntrantsStrategic Analysis and Forecasts of the Indian Recombinant Interferon MarketMarket OverviewRevenue Forecasts (1999–2004)End-User PerspectivesPricing TrendsCompetitive StructureMarket Share AnalysisProduct AnalysisNew EntrantsMarket Analysis of the Others MarketMarket Analysis of the Others MarketIndian Biopharmaceuticals Market, The Indian Monoclonal Antibodies Market (2001–2004)Total Market AnalysisMarket Overview and DefinitionsMarket Engineering Measurement AnalysisStrategic Analysis and Forecasts of the Indian Market for Monoclonal Antibodies Used in Leukemias and LymphomasMarket OverviewClassification of Leukemias and LymphomasRevenue Forecasts (2001–2004)Methodology for Calculation of the MAB Market for Leukemias and LymphomasCompetitive StructureProduct AnalysisGlobal Market TrendsProducts in the PipelineStrategic Analysis and Forecasts of the Indian Solid Tumors Monoclonal Antibodies MarketMarket Overview and DefinitionsRevenue Forecasts (2001–2004)Competitive StructureProduct AnalysisProducts in the Pipeline: A Global PictureIndian Biopharmaceuticals Market, Strategic RecommendationsBiopharmaceuticals Market Analysis: A SnapshotBiopharmaceuticals Market Analysis: A SnapshotAccessing Technology through Strategic Alliances and Licensing AgreementsAdopt New Patenting TypesMulti-Factor Analysis to Decide on Optimum PricingPhysician Education Programs to Increase Market PenetrationAdopting a ‘Complete Care’ ApproachImplementing Pharmacoeconomics to Evaluate Actual Costs of TherapyInitiating Tie Ups with Diagnostic LabsIndian Biopharmaceuticals Market, Database of Key Industry ParticipantsDatabase of Key Industry ParticipantsDatabase of Key Industry ParticipantsIndian Biopharmaceuticals Market, Decision Support DatabaseCausal FactorsIncidence of Bladder CancerIncidence of Breast CancerIncidence of Colorectal CancerIncidence of Liver CancerIncidence of Lung CancerIncidence of Prostrate CancerIncidence of Stomach CancerPrevalence of Diabetes Prevalence Percent of diabetes OthersNumber of Biotechnology CompaniesNumber of Employees in Biotech Sector




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.